CD8A and neoplasm: In cancer cells, FSTL3 prevented the ubiquitination and degradation of c-Myc through interaction with c-Myc, triggered the transcriptional expression of downstream PDL1 and IDO1, and thus blocked the anti-tumor effect of CD8+ T cells and enhanced the infiltration of Tregs (Fig. 8D).